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provided by dual-energy CT (DECT) compared to single-
energy CT (SECT) can be clinically used to reduce CT-based 
range uncertainties and to analyze intra- and interpatient 
tissue variations. First, a DECT scan protocol was optimized 
and clinically introduced. Second, in a first analysis patient 
DECT scans were evaluated concerning CT number variability. 
 
Material and Methods: After an experimental analysis of 
several CT scan settings concerning beam hardening, image 
quality and planned dose distribution using tissue surrogates, 
head and body phantoms and real tissues, an optimized and 
standardized DECT protocol (voltages: 80/140 kVp, kernel: 
D34) is clinically applied for patients treated with protons. 45 
planning and 360 control DECT scans of overall 70 patients 
were acquired with a single-source DECT scanner (Siemens 
SOMATOM Definition AS) until October 2015. Contouring and 
treatment planning are performed on pseudo-monoenergetic 
CT scans (MonoCT) derived by a weighted sum of both CT 
datasets. 25 patients with different tumor sites (head, head 
& neck, prostate, pelvis) and overall 200 DECT scans were 
initially investigated to evaluate intra- and interpatient 
tissue variabilities. Based on the frequency distribution of 
voxelwise 80/140kVp CT number pairs, a linear correlation of 
low-density, soft and bony tissues can be determined, 
respectively. 
 
Results: A DECT-based MonoCT of 79 keV is found optimal for 
proton treatment planning. Assuming identical CT dose to a 
SECT scan, the MonoCT shows a signal-to-noise ratio 
increased by 8% and a CT number constancy raised by 23% on 
average and up to 69% for bones. Consequently, the current 
uncertainties of a heuristic conversion of CT numbers into 
stopping power ratios (SPR) using a look-up table are 
reduced. 
Evaluation of patient variability revealed that 80/140kVp CT 
number pairs of human tissues are on average well described 
by linear correlations with a slope (± σ) of (1.023 ± 0.006) for 
low-density, (0.825 ± 0.008) for soft and (0.696 ± 0.006) for 
bony tissues. The slope variation between different patients, 
independent from tumor site and patient size, is comparable 
to the variability between different control DECT scans of 
one patient (σ of about 1-3%). However, a band of CT number 
pairs deviating from the mean linear correlation, e.g. caused 
by image noise and partial volume effects, reveals potential 
insuperable uncertainties of a voxel-based heuristic CT 
number-to-SPR conversion. 
 
 
 
Conclusion: The clinical application of DECT-based MonoCT 
can contribute to a more precise range prediction. Further 
improvements are expected from a direct, non-heuristic SPR 
calculation, which is not yet clinically available. The further 
growing DECT patient database enables not only a detailed 
analysis of intra- and interpatient variations, but also a 
robustness analysis for different direct SPR prediction 
approaches. 
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Purpose or Objective: To develop an image analysis 
approach for generation of the synthetic CT for MR-only 
radiotherapy of head and neck (H&N) cancer patients. 
 
Material and Methods: Eleven sets of CT and MRI (in-phase, 
Philips mDixon sequence) scans were randomly selected from 
a pool of H&N cancer patients. A bias field correction 
algorithm was primarily applied to each MRI scan to eliminate 
the intensity variation due to B0 and B1 field inhomogeneity 
and tissue susceptibility effect. A landmark-based MRI 
standardization technique was then used to standardize the 
MR intensity histograms wherein each landmark, total of 4, 
corresponds to a different histogram extremum. Using a rigid 
+ deformable registration, CT scan from each patient was 
registered to the standardized MRI to construct an atlas of 
CT-MRI. To improve the performance of the registration, 
bone intensity in the CT image was suppressed to assimilate 
CT and MRI scans. CT image is initially clustered into classes 
of air, bone and soft tissue. The cluster center of the bone 
class is then transformed to the air class to suppress the bone 
signal. To synthesize CT for a new patient, using the 
displacement fields achieved by registering each MRI in the 
atlas to the new patient MRI, all CTs from the atlas were also 
deformed onto the new patient. A generalized registration 
error (GRE) metric was then calculated as a measure of 
goodness of local registration between each pair of MRIs. GRE 
is the Euclidean distance of the mean normalized local mean, 
variance and entropy of the difference map between the two 
registered standard MRIs. The synthetic CT value at each 
point would be the average of GRE weighted CTs from all CT 
scans in the atlas. To evaluate our proposed method, the 
mean absolute error (MAE) between the synthetic CT and the 
original CT was computed over the entire CT and air and 
bone regions in a leave-one-out scheme. The efficiency of 
our proposed registration scheme was also compared with 
commercial software. Comparison of the dose plan between 
the original and synthetic CT is also ongoing. 
 
 
 
Results: MAE between the original and the synthetic CT was 
67 ± 9, 114 ± 22, and 116 ± 9 HU for the entire image, air and 
bone regions, respectively. We found that our proposed 
registration strategy and GRE metric each could lower up to 
30% and 15% of the MAE over the entire CT and up to 50% and 
40% in the MAE of the bone regions. Our primary dose 
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calculation revealed highly consistent results between the 
original and the synthetic CT. 
 
 
 
Conclusion: A multi-atlas based approach was presented in 
this work for generation of the synthetic CT for MR only 
radiotherapy of the head & neck cancer patients. While the 
registration scheme presented in this work enhances the 
performance of the atlas propagation, generalized 
registration error (GRE) helps to construct a better synthetic 
CT using a locally more similar atlas. 
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Purpose or Objective: Introducing an MRI-only workflow into 
the radiotherapy clinic, requires that MR-images can be used 
both for treatment planning calculations and for patient 
positioning. The two-fold aim of this study was to evaluate 
the use of MR-images with respect to 1) the accuracy of 
treatment planning dose calculations, and 2) the reliability of 
fiducial marker identification for patient positioning. 
 
Material and Methods: Synthetic CT images (sCT) were 
generated using the Statistical Decomposition Algorithm 
(SDA, MriPlanner, Spectronic Medical AB, Sweden). The 
algorithm uses a T2-weighted MRI for sCT generation, based 
on a multi-template assisted classification method. In order 
to exclude the effect of geometrical distortions and patient 
deformation owing to reposition between imaging sessions, a 
registered CT (rCT) was constructed by deformable 
registration with the MR using the Elastix toolbox. 
 
 
 
Five-field IMRT plans (both 6 and 10 MV) were created for six 
patients, using the Eclipse treatment planning system (Varian 
Medical Systems, Palo Alto, CA). Final dose calculations were 
made using the anisotropic analytical algorithm (AAA). The 
rCT was used for the initial treatment planning and the plan 
was recalculated on the sCT. Thus, the two treatment plans 
created for each patient had the same number of monitor 
units for each field. The resulting dose distributions from the 
rCT- and sCT-treatment plans were compared based on a set 
of dose volume histogram criteria according, and by using 
gamma evaluation.  
The reliability of the MRI-based fiducial marker identification 
was evaluated by an observer study. For this part of the 
study, the position of gold fiducial markers were determined 
by six independent observers using an MRI sequence 
dedicated for marker identification (LAVA-flex). Each marker 
position, three for each patient, were compared between the 
observers. The observers graded (one to five, were five 
represents the highest level of confidence) their confidence 
by which the markers for each patient were identified. 
 
Results: The mean dose differences to PTV between plans 
based on sCT and rCT were -0.1%±0.3% (1 s.d) (6MV) and -
0.2%±0.2% (1 s.d) (10 MV). Gamma analysis showed pass rates 
ranging between 98% and 100% for both energies, with 
gamma criteria of 1%/2mm (local dose deviation). The mean 
standard deviation of the marker position, as determined by 
the observers, was 0.6 mm in all directions (x, y and z). One 
marker identification result was excluded due to an incorrect 
identification by one observer. The confidence grading 
ranged between 2 and 5. 
 
Conclusion: This work demonstrates that SDA can provide 
sufficient dosimetric accuracy for an MRI only workflow for 
prostate cancer patients. However, gold fiducials cannot be 
identified using LAVA-flex with high enough confidence and 
further work is needed to develop methods for marker 
identification in an MRI only workflow. 
 
OC-0157 
Prostate fiducial markers detection with the use of 
multiparametric-MRI 
C.D. Fernandes
1The Netherlands Cancer Institute, Department of Radiation 
Oncology, Amsterdam, The Netherlands 
1, C. Dinh1, L.C. Ter Beek2, M. Steggerda1, M. 
Smolic1, L.D. Van Buuren1, P.J. Van Houdt1, U.A. Van der 
Heide1 
2The Netherlands Cancer Institute, Department of Radiology, 
Amsterdam, The Netherlands 
 
Purpose or Objective: Prostate cancer patients scheduled 
for EBRT are often implanted with fiducial markers for 
position verification. A precondition for an MR-only workflow 
is the possibility to identify them on MRI. The markers 
present as signal voids in most images and their apparent 
position depends on their shape and orientation relative to 
the magnetic field. Rather than acquiring a sequence for this 
single purpose, we propose to use a model for the automatic 
detection of fiducial markers combining information from the 
entire multiparametric (mp) MRI protocol used for target 
delineation. 
 
Material and Methods: Thirty prostate cancer patients 
scheduled for EBRT were implanted with 2-3 gold fiducial 
markers (0.9x3mm). A mp-MRI (T1w, T2w, B0-mapping and 
mDIXON) was performed using a 3T MRI (Achieva, Philips) and 
a CT with a 24-slice CT scanner (Somatom-Sensation-Open, 
Siemens).The reference position of the markers was based on 
the segmented CT images. The MRI was registered to the CT 
and resampled to the grid of 0.9x0.9x3mm3. A logistic 
regression model was developed to estimate the location of 
the markers based on the following MRI features: signal 
intensity, mean, median, min, max and standard deviation 
values in a kernel of 3x3x3vox and a multi-scale blobness 
filter [1] of the prostate region. The model was cross-
validated using a leave-one-out method. Performance was 
assessed using features from each separate imaging sequence 
and by combining the features from all sequences. Voxels 
detected as markers by the model were grouped into 
clusters. We defined the probability of each cluster 
candidate as the highest probability value of all voxels within 
it. Results were further post-processed by selecting the n(i) 
highest probability clusters, where n(i) is the number of 
markers implanted in patient i. Results were classified as a 
false positive (FP) if the distance between the reference 
